- As all people age they become at risk for developing illness related to the decline of important organ-systems. Some people with HIV appear to be at heightened ...
- On average, HIV-positive adults appear to be at increased risk for aging-related complications. One potential strategy to reduce this risk is to engage in ...
- In July 2018 Health Canada licensed the sale and use of Biktarvy for the treatment of HIV infection. Biktarvy, manufactured by Gilead Sciences, is supplied as ...
- When used as part of combination HIV therapy (ART), the class of drugs called integrase inhibitors has potent anti-HIV activity and is generally well tolerated. ...
- Many studies have found that some HIV-positive people tend to have bones that are not as thick or dense as they ought to be. Such bones have reduced bone ...
- There are several nutrients and activities that can help improve bone health and bone mineral density. In this issue of TreatmentUpdate, we underscore some of ...
- As children grow, so do their bones, as new bone tissue is placed on top of existing bones, particularly in the legs and backbones. This process of lengthening ...
- A placebo-controlled clinical trial called iPrEX was conducted to assess the safety and effectiveness of daily Truvada (a fixed-dose combination of two drugs in ...
- Several years ago a team of researchers at the Albert Einstein College of Medicine in The Bronx, New York, who specialized in women’s health issues ...
- As women age, their bodies undergo complex changes that affect many aspects of their health. Menopause is one such change, driven by altered hormonal levels. ...
- Most research on changes in bone density in HIV-positive women has focused on women before they have entered menopause. Due to hormonal changes associated with ...
- A group of drugs called bisphosphonates has been used for the past two decades to improve bone density and reduce the risk of fractures. These drugs were ...